Skip to main content

Achilles Therapeutics plc American Depositary Shares (ACHL)

About The Company

ACHL Stock Market Logo

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

IPO Year Sector Industry
2021 Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Achilles Therapeutics plc American (ACHL) Latest News

Company Contact & Address (ACHL)

Corporate Headquarters Phone Website
W6 8PW,
United Kingdom
+44 2081544600 Official ACHL Website

ACHL Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Biological Products (No Diagnostic Substances) Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ACHL

Jobs & Employment at Achilles Therapeutics plc American

LinkedIn Company Page
Official Career & Employment Page See LinkedIn page for the careers, jobs, employment details.

Related & Similar Stock Symbols

ZTR Stock Market Price & News


Virtus Total Return Fund Inc.

ERYP Stock Market Price & News


Erytech Pharma S.A. American Depositary Shares

TAL Stock Market Price & News


TAL Education Group American Depositary Shares